Technical analyst Amrut Deshmuk of Way2Wealth has maintained 'buy' rating on at Rs 154 Limited stock to achieve a target of Rs 164.

According to analyst, the investors can buy the stock at Rs 154 with a stop loss of Rs 148.

The stock of the company, on March 04, closed at Rs 150.15 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 187.50 and a low of Rs 129 on BSE.

Current EPS & P/E ratio stood at 3.01 and 50.18 respectively.

Fortis Global Healthcare Holdings today announced it has entered Sri Lankan market by getting hold of 28.6% equity stake in Lanka Hospitals Corporation Plc.

The deal is valued at over Rs 160 crore.

Fortis Global Healthcare Executive Chairman Malvinder Mohan Singh stated, "Lanka Hospitals is the first step for Fortis Global to build its healthcare business interest in one of the fastest growing economies in Asia."

"It is one of the most advanced and comprehensive healthcare facility in Sri Lanka. We believe there are tremendous opportunities for the hospital's expansion and we will support the company's management in realising such growth," Mr. Singh added.

According to Fortis functionaries, the agreement is worth $ 36.3 million, accordingly valuing the Sri Lankan hospital's complete equity stake at $126.92 million.

During the last month, Fortis group has made its initial acquirement in Singapore, seven months after failing to adopt health-care company Parkway Holdings.

Fortis Global Healthcare, the sister concern of New Delhi-listed Fortis Healthcare, declared that it will pay Singapore-listed First Real Estate Investment Trust a sum of $33 million for a cancer hospital being established in Adam Road.

For the three month period ended December 1010, Fortis Healthcare has recorded a consolidated net profit of Rs 345 million as against Rs 217.40 million during the same period of 2009.

Company's total income surged to Rs 4,083.60 million for the three month period ended December 2010 as against Rs 2,411.80 million for the same period of 2009.